pharmaphorum

MARCH 20, 2024

Vicore gets FDA breakthrough status for Almee, a cognitive behavioural therapy (CBT) digital health therapy used to support people with pulmonary fibrosis

FDA 116

FDA 116

STAT

JANUARY 31, 2024

Novo also projected double-digit growth in sales and operating profit for 2024. In response to concerns over multi-million-dollar price tags for new gene therapies for sickle cell disease, the U.S. In response to concerns over multi-million-dollar price tags for new gene therapies for sickle cell disease, the U.S.

96

96

pharmaphorum

OCTOBER 18, 2022

Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the latter’s near-field communication (NFC) tags in injectable devices. The Injay tag can confirm a complete injection and transfer that information via an NFC reader to a smartphone or tablet for review by a healthcare professional.

Communication 52

Communication 52

PharmaShots

MARCH 17, 2023

5-Adapted Bivalent Booster to Treat COVID-19 in Children ≤5 Years Date: Mar 15, 2023 | Tags: Pfizer, BioNTech, Omicron BA.4/BA.5-Adapted 5-Adapted Bivalent Booster to Treat COVID-19 in Children ≤5 Years Date: Mar 15, 2023 | Tags: Pfizer, BioNTech, Omicron BA.4/BA.5-Adapted

FDA 40

FDA Labelling 40

pharmaphorum

NOVEMBER 24, 2021

Digital health company Pear Therapeutics has won FDA breakthrough device status for reSET-A, its development-stage prescription digital therapeutic (DTx) for people with alcohol-use disorder. The post Pear claims breakthrough tag for alcohol use disorder DTx appeared first on. Photo by thom masat on Unsplash.

FDA 59

FDA 59

Digital Pharmacist

MARCH 28, 2024

Also, be sure to tag the Parkinson’s Foundation in any post or use the hashtag #ABCsOfPD so they can share your information as well. If you offer Medication Therapy Management or other occupational therapy programs, this is a great time to highlight these at FOH as they can be very beneficial in helping patients with Parkinson’s Disease.

Health and Personal Care Stores 68

Health and Personal Care Stores Hospitals 68

pharmaphorum

JANUARY 11, 2022

A prescription digital therapeutic (DTx) for leukaemia patients developed by Blue Note Therapeutics has been awarded breakthrough device status by the FDA. Breakthrough designations can speed up the development of new therapies, making them available to patients sooner.

FDA 64

FDA Chemotherapy Hospitals 64